Cancer Incidence and Mortality among Black Individuals, New York State Excl New York City, 2016-2020

Source: New York State Cancer Registry

Site of Cancer Incidence Mortality
Males and Females Males Females Males and Females Males Females
Average Annual Cases Rate per 100,000 Population 95% CI Average Annual Cases Rate per 100,000 Males 95% CI Average Annual Cases Rate per 100,000 Females 95% CI Average Annual Deaths Rate per 100,000 Population 95% CI Average Annual Deaths Rate per 100,000 Males 95% CI Average Annual Deaths Rate per 100,000 Females 95% CI
All Invasive Malignant Tumors 5,223.2 465.6 459.8-471.4 2,687.2 545.9 536.2-555.7 2,536.0 411.1 403.9-418.5 1,567.4 147.8 144.5-151.2 774.8 177.7 171.8-183.7 792.6 129.3 125.2-133.4
Oral cavity and pharynx 92.2 8.0 7.2-8.8 61.6 11.9 10.5-13.3 30.6 4.9 4.2-5.8 21.4 1.9 1.6-2.3 16.2 3.3 2.6-4.2 5.2 0.8 0.5-1.2
Esophagus 39.8 3.8 3.2-4.3 25.8 6.0 4.9-7.1 14.0 2.2 1.7-2.9 30.8 2.9 2.4-3.4 22.2 5.2 4.2-6.3 8.6 1.4 1.0-1.8
Stomach 115.6 10.9 10.0-11.8 59.6 13.0 11.4-14.6 56.0 9.4 8.3-10.6 44.8 4.3 3.7-4.9 25.2 5.6 4.6-6.8 19.6 3.2 2.6-3.9
Colorectal 436.2 39.6 37.9-41.4 224.4 47.4 44.5-50.4 211.8 34.3 32.2-36.5 147.0 13.7 12.7-14.8 77.6 17.3 15.6-19.3 69.4 11.3 10.1-12.6
Colon excluding rectum 315.2 29.0 27.6-30.5 154.0 33.4 30.9-35.9 161.2 26.2 24.4-28.1 122.2 11.4 10.5-12.4 64.0 14.4 12.8-16.2 58.2 9.4 8.4-10.6
Rectum & rectosigmoid 121.0 10.6 9.8-11.5 70.4 14.0 12.5-15.6 50.6 8.1 7.1-9.2 24.8 2.3 1.9-2.7 13.6 2.9 2.2-3.7 11.2 1.9 1.4-2.4
Liver / intrahepatic bile duct 128.0 10.7 9.9-11.6 91.4 17.3 15.7-19.0 36.6 5.6 4.8-6.5 81.8 7.2 6.5-8.0 55.8 11.1 9.8-12.6 26.0 4.2 3.5-5.0
Pancreas 180.8 16.9 15.8-18.0 84.0 18.0 16.3-19.9 96.8 15.8 14.4-17.3 132.0 12.6 11.6-13.6 63.0 14.0 12.4-15.7 69.0 11.4 10.2-12.7
Larynx 36.4 3.1 2.7-3.6 28.6 5.7 4.8-6.8 7.8 1.2 0.8-1.6 11.0 1.0 0.7-1.3 8.8 1.9 1.4-2.6 2.2 0.3 0.2-0.6
Lung and bronchus 589.8 53.9 51.9-55.9 307.6 67.0 63.6-70.7 282.2 45.1 42.7-47.5 320.6 29.9 28.4-31.4 178.8 40.9 38.1-43.8 141.8 22.6 20.9-24.4
Melanoma of the skin 11.2 1.1 0.8-1.4 4.6 1.0 0.6-1.5 6.6 1.1 0.7-1.5 2.4 0.2 0.1-0.4 1.4 0.3 0.1-0.6 1.0 0.2 0.1-0.4
Female breast             794.4 129.5 125.5-133.7             142.0 23.2 21.5-25.0
Cervix uteri             44.4 7.3 6.3-8.3             14.2 2.3 1.8-3.0
Corpus uterus and NOS             198.0 31.0 29.1-33.0             53.6 8.6 7.6-9.7
Ovary             49.0 7.9 6.9-8.9             28.2 4.7 3.9-5.5
Prostate       1,056.8 205.3 199.6-211.2             106.8 28.1 25.7-30.7      
Testis       10.2 1.6 1.2-2.2             0.0 0.0 0.0-0.2      
Urinary bladder (incl. in situ) 132.2 12.5 11.5-13.5 89.6 20.3 18.4-22.4 42.6 7.0 6.1-8.1 25.2 2.6 2.2-3.1 15.4 4.1 3.2-5.2 9.8 1.6 1.2-2.2
Kidney and renal pelvis 210.0 18.5 17.4-19.7 132.6 25.9 23.9-28.1 77.4 12.6 11.4-14.0 25.0 2.4 2.0-2.8 16.0 3.4 2.7-4.3 9.0 1.5 1.1-2.1
Brain and other central nervous system 47.0 4.1 3.6-4.6 24.2 4.7 3.8-5.6 22.8 3.7 3.0-4.4 26.6 2.3 2.0-2.8 13.0 2.4 1.8-3.1 13.6 2.2 1.7-2.8
Thyroid 118.4 10.4 9.5-11.3 24.4 4.7 3.9-5.7 94.0 15.6 14.2-17.1 6.2 0.6 0.4-0.9 2.6 0.6 0.3-1.1 3.6 0.6 0.4-1.0
Hodgkin lymphoma 31.6 2.7 2.2-3.1 16.2 2.9 2.3-3.7 15.4 2.4 1.9-3.1 2.2 0.2 0.1-0.3 1.8 0.4 0.2-0.7 0.4 0.1 0.0-0.2
Non-Hodgkin lymphomas 171.4 15.5 14.4-16.6 94.2 19.2 17.4-21.1 77.2 12.7 11.4-14.0 42.0 3.9 3.4-4.5 24.8 5.4 4.5-6.5 17.2 2.8 2.3-3.5
Myeloma 159.4 14.7 13.6-15.7 81.6 17.6 15.8-19.5 77.8 12.6 11.3-13.9 49.4 4.9 4.3-5.6 25.2 6.3 5.2-7.6 24.2 4.1 3.4-4.9
Leukemias 121.2 10.9 10.0-11.8 63.8 13.2 11.7-14.8 57.4 9.3 8.3-10.5 51.8 4.9 4.3-5.6 27.0 6.2 5.1-7.4 24.8 4.1 3.4-4.9

Notes

  • Incidence data are provisional, November 2022.
  • Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
  • Rates based on fewer than 4 cases or deaths per year are unstable and should be used with caution. NOS = Not otherwise specified.
  • NYSCR mortality statistics might differ slightly from official mortality statistics due to the availability of additional demographic information.